Read + Share
Ikeuchi H, Hirose T, Ikegami M, Takamochi K, et al. Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors
in a highly heterogeneous tumor model. Oncogene 2022;41:2470-2479.
PMID: 35304574
|
 |
|
Ikeuchi H, Hirose T, Ikegami M, Takamochi K, et al. Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors
in a highly heterogeneous tumor model. Oncogene 2022;41:2470-2479.
PMID: 35304574
|
|
|
|